News

We are an emerging, oncology-focused, clinical stage pharma at the intersection of Artificial Intelligence, Genomics, and Machine Learning.
Our mission is to deliver precision oncology therapies to the right cancer patients with significantly reduced costs and timelines.
Explore
01
04

Press

We are an emerging, oncology-focused, clinical stage pharma at the intersection of Artificial Intelligence, Genomics, and Machine Learning.
Our mission is to deliver precision oncology therapies to the right cancer patients with significantly reduced costs and timelines.
Explore
02
04

Social Media

We are an emerging, oncology-focused, clinical stage pharma at the intersection of Artificial Intelligence, Genomics, and Machine Learning.
Our mission is to deliver precision oncology therapies to the right cancer patients with significantly reduced costs and timelines.
Explore
03
04

Videos

We are an emerging, oncology-focused, clinical stage pharma at the intersection of Artificial Intelligence, Genomics, and Machine Learning.
Our mission is to deliver precision oncology therapies to the right cancer patients with significantly reduced costs and timelines.
Explore
04
04

Taking a novel approach to drug development

Media

Find the latest news coverage and press releases on Lantern Pharma below. For more content from Lantern Pharma, you can browse our social media feed for condensed updates, or explore our videos on a variety of topics related to our company, culture, and development.

News

Lantern Pharma is proud to be featured by a multitude of media outlets. Our goal is to crush cancer, and by spreading word of our innovative technology, we hope to open the door for more collaborations and partnerships to empower us in developing the right treatments for the right patients.

Explore

Press

 View Lantern’s most up-to-date press releases for important information about our pipeline, technology, collaborations, and more.

Explore

Social Media

Lantern’s LinkedIn and Twitter pages contain condensed versions of our most important updates.

Explore

Videos

See videos from Lantern Pharma, including those about what it’s like to work at our cutting-edge biotech, details on the various drugs we are developing to bring to the right cancer patients, and interviews with CEO Panna Sharma about the state of our company.

Explore

Newsletter

The Lantern Pharma Newsletter is a monthly communication that provides succinct and frequent updates about Lantern, our RADR® AI and ML platform, and our pipeline of drug programs. Subscribe to the newsletter to receive it by email or see the most recent editions by clicking on the link below.

Explore

Webinars

Lantern Pharma has had the opportunity to host several Key Opinion Leader webinars with world-renowned experts in various fields of oncology and drug discovery. Click on the link below to learn more.

Explore

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.